Notes

Slide Show

Outline

1	CLSC412 HEMOSTASIS
2	Unit Objectives - 1
3	Unit Objectives - 2
4	Unit Objectives - 3
5	Specimen Requirements
6	Specimen Integrity
7	Needle Selection for Specimen
8	Point-of-Care Testing
9	EDTA & Hemostasis Testing
10	Specimen Transport & Storage
11	Platelet Rich Plasma (PRP)
12	Platelet Poor Plasma (PPP)
13	Platelet Function Tests
14	Bleeding Time - 1
15	Bleeding Time - 2
16	Platelet Function Assay - 1
17	Platelet Function Assay - 1
18	Platelet Aggregometry Assay - 1
19	Plt Aggregometry with PRP
20	Plt Aggregometry with Whole-blood
21	Platelet Lumiaggregometry
22	Platelet Aggregating Agonists - 1
23	Platelet Aggregating Agonists - 2
24	Platelet Aggregating Agonists - 3
25	Platelet Aggregating Agonists - 4
26	Platelet Aggregating Agonists - 5
27	Aggregating Agonists - Summary
28	HIT with Thrombosis
29	Tests for HIT with Thrombosis
30	Corrected Platelet Count Increment
31	CLOT-BASED SCREENING TESTS
32	ACT
33	PT - 1
34	PT - 2
35	PT - 3
36	PT - 4
37	PT – Interference - 1
38	PT – Interference - 2
39	aPTT – 1
40	aPTT – 2
41	Clinical Utility of aPTT
42	Prolongation of aPTT
43	Limitations of aPTT
44	aPTT mixing studies - 1
45	aPTT mixing studies - 2
46	Thrombin Clotting Time - 1
47	Thrombin Clotting Time - 2
48	Reptilase Test - 1
49	Reptilase Test - 2
50	Fibrinogen Assay - 1
51	Fibrinogen Assay - 2
52	aPTT Single-Factor Assay - 1
53	aPTT Single-Factor Assay - 2
54	PT Single-Factor Assay - 1
55	Factor XIII Assays
56	Fibrinolytic Assays
57	Evaluation of Hemostasis
58	Adjusting Blood to sodium citrate - 1
59	Adjusting Blood to sodium citrate - 2
60
61